1. Home
  2. ADVM vs LWAY Comparison

ADVM vs LWAY Comparison

Compare ADVM & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • LWAY
  • Stock Information
  • Founded
  • ADVM 2006
  • LWAY 1986
  • Country
  • ADVM United States
  • LWAY United States
  • Employees
  • ADVM N/A
  • LWAY N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • LWAY Packaged Foods
  • Sector
  • ADVM Health Care
  • LWAY Consumer Staples
  • Exchange
  • ADVM Nasdaq
  • LWAY Nasdaq
  • Market Cap
  • ADVM 140.6M
  • LWAY 280.2M
  • IPO Year
  • ADVM 2014
  • LWAY 1987
  • Fundamental
  • Price
  • ADVM $7.30
  • LWAY $22.31
  • Analyst Decision
  • ADVM Strong Buy
  • LWAY Buy
  • Analyst Count
  • ADVM 6
  • LWAY 1
  • Target Price
  • ADVM $28.17
  • LWAY $25.00
  • AVG Volume (30 Days)
  • ADVM 144.8K
  • LWAY 130.5K
  • Earning Date
  • ADVM 11-07-2024
  • LWAY 11-11-2024
  • Dividend Yield
  • ADVM N/A
  • LWAY N/A
  • EPS Growth
  • ADVM N/A
  • LWAY 144.62
  • EPS
  • ADVM N/A
  • LWAY 0.90
  • Revenue
  • ADVM N/A
  • LWAY $176,780,000.00
  • Revenue This Year
  • ADVM N/A
  • LWAY $24.40
  • Revenue Next Year
  • ADVM $5,848.83
  • LWAY $11.11
  • P/E Ratio
  • ADVM N/A
  • LWAY $24.78
  • Revenue Growth
  • ADVM N/A
  • LWAY 16.99
  • 52 Week Low
  • ADVM $6.38
  • LWAY $9.06
  • 52 Week High
  • ADVM $29.70
  • LWAY $28.61
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 55.10
  • LWAY 69.71
  • Support Level
  • ADVM $6.54
  • LWAY $19.60
  • Resistance Level
  • ADVM $7.20
  • LWAY $22.37
  • Average True Range (ATR)
  • ADVM 0.35
  • LWAY 1.31
  • MACD
  • ADVM 0.06
  • LWAY -0.01
  • Stochastic Oscillator
  • ADVM 67.26
  • LWAY 84.08

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products primarily through direct sales force, brokers, and distributors.

Share on Social Networks: